These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8882610

  • 1. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
    Vázquez M, Merlos M, Adzet T, Laguna JC.
    Br J Pharmacol; 1996 Mar; 117(6):1155-62. PubMed ID: 8882610
    [Abstract] [Full Text] [Related]

  • 2. Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation.
    Alegret M, Cerqueda E, Ferrando R, Vázquez M, Sánchez RM, Adzet T, Merlos M, Laguna JC.
    Br J Pharmacol; 1995 Apr; 114(7):1351-8. PubMed ID: 7606338
    [Abstract] [Full Text] [Related]

  • 3. Different effects of fibrates on the microsomal fatty acid chain elongation and the acyl composition of phospholipids in guinea-pigs.
    Vázquez M, Alegret M, López M, Rodríguez C, Adzet T, Merlos M, Laguna JC.
    Br J Pharmacol; 1995 Dec; 116(8):3337-43. PubMed ID: 8719816
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of fibrates on the acyl composition of microsomal phospholipids in rats.
    Vázquez M, Muñoz S, Alegret M, Adzet T, Merlos M, Laguna JC.
    Br J Pharmacol; 1995 Oct; 116(3):2067-75. PubMed ID: 8640347
    [Abstract] [Full Text] [Related]

  • 5. Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.
    Alegret M, Ferrando R, Vázquez M, Adzet T, Merlos M, Laguna JC.
    Br J Pharmacol; 1994 Jun; 112(2):551-6. PubMed ID: 7915611
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.
    Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
    [Abstract] [Full Text] [Related]

  • 7. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF, de Graaf J, Wittekoek ME, Bredie SJ, Demacker PN, Kastelein JJ.
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [Abstract] [Full Text] [Related]

  • 8. Fenofibrate protects lipoproteins from lipid peroxidation: synergistic interaction with alpha-tocopherol.
    Chaput E, Maubrou-Sanchez D, Bellamy FD, Edgar AD.
    Lipids; 1999 May; 34(5):497-502. PubMed ID: 10380122
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L, Szostak WB.
    Eur J Clin Pharmacol; 1991 May; 40(1):33-41. PubMed ID: 2060543
    [Abstract] [Full Text] [Related]

  • 10. Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.
    Belkebir-Mesbah D, Bonnefont-Rousselot D, Frey-Fressart V, Moinard C, Delattre J, Vasson MP.
    Endocrine; 1999 Jun; 10(3):233-42. PubMed ID: 10484287
    [Abstract] [Full Text] [Related]

  • 11. Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia.
    Smith WG, Wang J, Dang AQ, Reeves C, Bibbs D, Faas FH.
    Clin Chim Acta; 2002 Aug; 322(1-2):77-84. PubMed ID: 12104084
    [Abstract] [Full Text] [Related]

  • 12. Fibric acids: effects on lipids and lipoprotein metabolism.
    Grundy SM, Vega GL.
    Am J Med; 1987 Nov 27; 83(5B):9-20. PubMed ID: 3318457
    [Abstract] [Full Text] [Related]

  • 13. Fibrates and triglyceride metabolism.
    Schwandt P.
    Eur J Clin Pharmacol; 1991 Nov 27; 40 Suppl 1():S41-3. PubMed ID: 2044642
    [Abstract] [Full Text] [Related]

  • 14. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ, Bastida S, Viejo JM, Terpstra AH.
    Eur J Nutr; 1999 Feb 27; 38(1):20-7. PubMed ID: 10338684
    [Abstract] [Full Text] [Related]

  • 15. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients.
    Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT.
    Eur J Clin Invest; 2001 Aug 27; 31(8):707-13. PubMed ID: 11473572
    [Abstract] [Full Text] [Related]

  • 16. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
    Haubenwallner S, Essenburg AD, Barnett BC, Pape ME, DeMattos RB, Krause BR, Minton LL, Auerbach BJ, Newton RS, Leff T.
    J Lipid Res; 1995 Dec 27; 36(12):2541-51. PubMed ID: 8847480
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS.
    Atherosclerosis; 1998 Jun 27; 138(2):271-80. PubMed ID: 9690910
    [Abstract] [Full Text] [Related]

  • 18. [Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia].
    Zeman M, Zák A, Tvrzická E, Konárková M, Stípek S.
    Cas Lek Cesk; 2002 Apr 12; 141(7):211-6. PubMed ID: 12053756
    [Abstract] [Full Text] [Related]

  • 19. Dietary flavonoids reduce lipid peroxidation in rats fed polyunsaturated or monounsaturated fat diets.
    Frémont L, Gozzélino MT, Franchi MP, Linard A.
    J Nutr; 1998 Sep 12; 128(9):1495-502. PubMed ID: 9732310
    [Abstract] [Full Text] [Related]

  • 20. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.